Literature DB >> 28550179

Cyp2c44 gene disruption is associated with increased hematopoietic stem cells: implication in chronic hypoxia-induced pulmonary hypertension.

Ryota Hashimoto1,2, Sachindra Raj Joshi1, Houli Jiang1, Jorge H Capdevila3, Ivan F McMurtry4, Michal Laniado Schwartzman1, Sachin A Gupte5.   

Abstract

We have recently demonstrated that disruption of the murine cytochrome P-450 2c44 gene (Cyp2c44) exacerbates chronic hypoxia-induced pulmonary artery remodeling and hypertension in mice. Subsequently, we serendipitously found that Cyp2c44 gene disruption also increases hematopoietic stem cell (HSC) numbers in bone marrow and blood. Therefore, the objective of the present study was to investigate whether CYP2C44-derived eicosanoids regulate HSC proliferation/cell growth and whether increased HSCs contribute to chronic hypoxia-induced remodeling of pulmonary arteries in Cyp2c44 knockout mice. Our findings demonstrated that lack of CYP2C44 epoxygenase, which catalyzed the oxidation of arachidonic acid to epoxyeicosatrienoic (EETs) and hydroxyeicosatetraenoic (HETE) acids, increases the numbers of 1) HSCs (CD34+, CD117+, and CD133+), 2) proangiogenic (CD34+CD133+ and CD34+CD117+CD133+) cells, and 3) immunogenic/inflammatory (CD34+CD11b+, CD133+CD11b+, F4/80+, CD11b+, and F4/80+CD11b+) macrophages in bone marrow and blood compared with wild-type mice. Among the various CYP2C44-derived arachidonic acids, only 15-HETE decreased CD117+ cell numbers when applied to bone marrow cell cultures. Interestingly, CD133+ and von Willebrand factor-positive cells, which are derived from proangiogenic stem cells, are increased in the bone marrow, blood, and lungs of mice exposed to chronic hypoxia and in remodeled and occluded pulmonary arteries of CYP2C44-deficient mice. In conclusion, our results demonstrate that CYP2C44-derived 15-HETE plays a critical role in downregulating HSC proliferation and growth, because disruption of the Cyp2c44 gene increased HSCs that potentially contribute to chronic hypoxia-induced pulmonary arterial remodeling and occlusion.NEW & NOTEWORTHY This study demonstrates that cytochrome P-450 2C44 plays a critical role in controlling the phenotype of hematopoietic stem cells and that when this enzyme is knocked out, stem cells are differentiated. These stem cells give rise to increased circulating monocytes and macrophages and contribute to the pathogenesis of chronic hypoxia-induced pulmonary artery remodeling and hypertension.
Copyright © 2017 the American Physiological Society.

Entities:  

Keywords:  arterial stiffness; bone marrow; lungs; mice; progenitor cells

Mesh:

Substances:

Year:  2017        PMID: 28550179      PMCID: PMC5582928          DOI: 10.1152/ajpheart.00785.2016

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  59 in total

Review 1.  The CYP P450 arachidonic acid monooxygenases: from cell signaling to blood pressure regulation.

Authors:  J H Capdevila; J R Falck
Journal:  Biochem Biophys Res Commun       Date:  2001-07-20       Impact factor: 3.575

Review 2.  Endothelial progenitor cells: mobilization, differentiation, and homing.

Authors:  Mihail Hristov; Wolfgang Erl; Peter C Weber
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-04-24       Impact factor: 8.311

Review 3.  CD133(+) cells isolated from various sources and their role in future clinical perspectives.

Authors:  Mirella Meregalli; Andrea Farini; Marzia Belicchi; Yvan Torrente
Journal:  Expert Opin Biol Ther       Date:  2010-10-11       Impact factor: 4.388

4.  Glucose-6-phosphate dehydrogenase plays a critical role in hypoxia-induced CD133+ progenitor cells self-renewal and stimulates their accumulation in the lungs of pulmonary hypertensive rats.

Authors:  Sukrutha Chettimada; Sachindra Raj Joshi; Abdallah Alzoubi; Sarah A Gebb; Ivan F McMurtry; Rakhee Gupte; Sachin A Gupte
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-07-25       Impact factor: 5.464

Review 5.  Epoxides and soluble epoxide hydrolase in cardiovascular physiology.

Authors:  John D Imig
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 37.312

6.  CYP2C44, a new murine CYP2C that metabolizes arachidonic acid to unique stereospecific products.

Authors:  Tracy C DeLozier; Cheng-Chung Tsao; Sherry J Coulter; Julie Foley; J Alyce Bradbury; Darryl C Zeldin; Joyce A Goldstein
Journal:  J Pharmacol Exp Ther       Date:  2004-04-14       Impact factor: 4.030

7.  Cyp2c44 epoxygenase in the collecting duct is essential for the high K+ intake-induced antihypertensive effect.

Authors:  Wen-Hui Wang; Chengbiao Zhang; Dao-Hong Lin; Lijun Wang; Joan P Graves; Darryl C Zeldin; Jorge H Capdevila
Journal:  Am J Physiol Renal Physiol       Date:  2014-06-25

Review 8.  Cellular and molecular basis of pulmonary arterial hypertension.

Authors:  Nicholas W Morrell; Serge Adnot; Stephen L Archer; Jocelyn Dupuis; Peter Lloyd Jones; Margaret R MacLean; Ivan F McMurtry; Kurt R Stenmark; Patricia A Thistlethwaite; Norbert Weissmann; Jason X-J Yuan; E Kenneth Weir
Journal:  J Am Coll Cardiol       Date:  2009-06-30       Impact factor: 24.094

9.  Opposing actions of angiopoietin-2 on Tie2 signaling and FOXO1 activation.

Authors:  Minah Kim; Breanna Allen; Emilia A Korhonen; Maximilian Nitschké; Hee Won Yang; Peter Baluk; Pipsa Saharinen; Kari Alitalo; Christopher Daly; Gavin Thurston; Donald M McDonald
Journal:  J Clin Invest       Date:  2016-08-22       Impact factor: 14.808

10.  Telocytes in human isolated atrial amyloidosis: ultrastructural remodelling.

Authors:  E Mandache; M Gherghiceanu; C Macarie; S Kostin; L M Popescu
Journal:  J Cell Mol Med       Date:  2010-12       Impact factor: 5.310

View more
  4 in total

1.  Statistical considerations in reporting cardiovascular research.

Authors:  Merry L Lindsey; Gillian A Gray; Susan K Wood; Douglas Curran-Everett
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-07-20       Impact factor: 4.733

2.  Pluripotent hematopoietic stem cells augment α-adrenergic receptor-mediated contraction of pulmonary artery and contribute to the pathogenesis of pulmonary hypertension.

Authors:  Ryota Hashimoto; Gregg M Lanier; Vidhi Dhagia; Sachindra R Joshi; Allan Jordan; Ian Waddell; Rubin Tuder; Kurt R Stenmark; Michael S Wolin; Ivan F McMurtry; Sachin A Gupte
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-01-08       Impact factor: 5.464

3.  Nonclassical Monocytes Sense Hypoxia, Regulate Pulmonary Vascular Remodeling, and Promote Pulmonary Hypertension.

Authors:  Yen-Rei A Yu; Yuryi Malakhau; Chen-Hsin A Yu; Stefan-Laural J Phelan; R Ian Cumming; Matthew J Kan; Lan Mao; Sudarshan Rajagopal; Claude A Piantadosi; Michael D Gunn
Journal:  J Immunol       Date:  2020-01-29       Impact factor: 5.422

4.  Cyp2c44-mediated decrease of 15-HETE exacerbates pulmonary hypertension.

Authors:  Gábor Á Fülöp; Andriy Yabluchanskiy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-06-16       Impact factor: 5.125

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.